Skip to main content

Table 2 Distribution of HCV genotypes in patients subjected to different types of treatments (N = 136)

From: Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients

HCV Genotypes Treatment type
  IFNα & RBV
(%)
PegIFN & RBV
(%)
3a 78(90.6) 33 (66)
3b None 1 (2)
1a 1 (1.2) 5 (10)
3a/1a None 4 (8)
3a/1b None 2 (4)
2b 1 (.7) none
Untypable 6 (6.9) 5 (10)
Total 86 50
  1. HCV: hepatitis C virus; INF: interferon; Peg: pegylated; RBV: ribavirin